Exercise program for nontuberculous mycobacterium lung disease
Part of Lungs & breathing clinical trials.
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with NTM lung disease and have symptoms like coughing or shortness of breath.
- A test for NTM bacteria in your sputum or lung samples came back positive in the last 6 months.
- You do not have heart disease, recent significant coughing up of blood, or muscle or bone problems that limit movement.
- You are able to read and understand a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a program of exercise and airway clearance education helps people with nontuberculous mycobacterial (NTM) lung disease. It aims to improve breathing and quality of life.
This study looks at how nutrition and immune cell activity relate to the progression of lung disease caused by nontuberculous mycobacteria (NTM). It may help doctors better understand and monitor this chronic infection.
This is a research registry that collects information from adults diagnosed with nontuberculous mycobacterial (NTM) lung disease. It may help doctors better understand the disease and improve care over time.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This trial tests a pulmonary rehabilitation program for people who have completed treatment for tuberculosis but still have breathing problems or limited exercise ability. The program aims to improve respiratory symptoms and daily function.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
Hear when a new Nontuberculous Mycobacterial Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.